Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Lefamulin for M. Genitalium Treatment Failures [Phase 1, Phase 2]

View source ↗

Summary

Terminated Phase 1/2 clinical trial assessing Lefamulin for treatment failures in Mycoplasma genitalium infection, with results posted on 2024-10-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenleta (lefamulin)

Snippet

Sponsor: University of Washington | Conditions: Mycoplasma Genitalium Infection | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-10-16